NLRP3 and type 2 diabetes mellitus: In recent years, multiple studies have shown that NLRP3 is activated in HCV-induced T2DM, triggering the proliferation of pancreatic MIN6 cells, apoptosis, and pyroptosis, leading to impaired pancreatic islet cell function and triggering T2DM [36, 37].